您的位置: 首页 > 农业专利 > 详情页

Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor
专利权人:
Pfizer Inc.
发明人:
Calvert, Alan Hilary,Hostomsky, Zdenek,Newell, David Richard,Plummer, Elizabeth Ruth,Steinfeldt, Heidi Marie,Thomas, Huw David,Stratford, Ian J.,Klamerus, Karen J.,Williams, Kaye Janine,Dewji, Mohamed
申请号:
AU2011253816
公开号:
AU2011253816A1
申请日:
2011.12.02
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2011253816A120120112.pdf#####-THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR Abstract The invention generally relates to use of 8-fluoro-2-{4-[(methylamino)methyl]pheny)}-1, 5 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one represented by Formula (1) as a chemosensitizer that enhances the efficacy of cytotoxic drugs or radiotherapy. The invention also relates to pharmaceutical combinations of 8-fluoro-2-{4-[(methylamino)methylpheny)}-1, 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, or a pharmaceutically acceptable salt thereof and at least one additional therapeutic agent, kits containing such combinations and methods of 10 using such combinations to treat subjects suffering from diseases such as cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充